BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,004,000 | -84.7% | 16,900 | -82.2% | 0.06% | -78.6% |
| Q4 2021 | $13,092,000 | +461.9% | 95,000 | +295.8% | 0.27% | +220.5% |
| Q2 2021 | $2,330,000 | -40.2% | 24,000 | -57.9% | 0.08% | -14.4% |
| Q1 2021 | $3,896,000 | -62.6% | 57,000 | -53.1% | 0.10% | -51.3% |
| Q4 2020 | $10,422,000 | +72.5% | 121,600 | +30.9% | 0.20% | -10.8% |
| Q3 2020 | $6,042,000 | +55.9% | 92,925 | +75.3% | 0.22% | -16.8% |
| Q2 2020 | $3,875,000 | +656.8% | 53,000 | +353.0% | 0.27% | +378.6% |
| Q2 2019 | $512,000 | – | 11,700 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |